Skip to main content
Table of Contents
Print

Does Medical Cannabis Work for Morning Stiffness Caused by Arthritis? 

Author: Dr. Clarissa Morton, PharmD

Morning stiffness is perhaps the most annoying arthritis symptom for a lot of individuals, complicating the process of getting going and beginning the day. Though some patients benefit from conventional therapies for treating their arthritis, others keep on seeking alternatives, including medical cannabis when prescribed by a doctor. 
Some arthritis patients report improvement in morning stiffness with medical cannabis prescribed under clinical guidance. This is largely due to the cannabinoids benefits that can help reduce inflammation and improve joint mobility. But how exactly does it work, and what do patients need to know before pursuing this treatment? 
This article is for educational purposes only. Medical cannabis in the UK can be prescribed by a specialist only, on the prescription of a specialist clinician. It is not first line treatment, and its prescribing must adhere to legal and medical standards. 

What Causes Morning Stiffness in Arthritis? 

Morning stiffness is a characteristic symptom of most forms of arthritis, especially rheumatoid arthritis (RA) and osteoarthritis (OA). Though the stiffness tends to resolve with activity, it may persist for a duration of an hour or more in more aggressive cases. 
This stiffness is usually due to inflammation within the joints, specifically surrounding the synovial membrane, the soft tissue that covers joint spaces. In rheumatoid arthritis, the immune system attacks joint linings unintentionally, leading to inflammatory chemicals known as cytokines. In osteoarthritis, chronic wear and tear can lead to low-grade inflammation and degeneration of cartilage. 
Arthritis symptoms such as morning stiffness, swelling, and pain are commonly exacerbated by overnight immobility. Overnight immobilization allows fluid to build up and inflammatory mechanisms to become amplified within the joints. 
Keeping joints mobile, reducing inflammation, and safeguarding joint function are central objectives of arthritis management, and some new treatments, such as medical cannabis relief guidance,

How Medical Cannabis Works in the Body 

Medical Cannabis is comprised of a variety of active substances known as cannabinoids, with the two best researched being CBD (cannabidiol) and THC (tetrahydrocannabinol). 
These cannabinoids bind with the body’s endocannabinoid system (ECS) – a sophisticated system of receptors (CB1 and CB2) used to manage pain, inflammation, mood, and sleep. Although science is ongoing, it’s believed that ECS contributes to the body’s equilibrium (homeostasis). 
• CBD is not psychoactive and has demonstrated anti-inflammatory and analgesic effects in preclinical research. 
• THC is psychoactive but can potentially decrease pain and facilitate sleep in some patients. 
 

The potential cannabinoid benefits for arthritis are to modulate inflammatory pathways and pain signaling. However, people vary in their responses, and much of the data is from preliminary studies or patient surveys. 
Solutions such as medical cannabis Releaf are tested for their potential to facilitate pain relief without the severe side effects of conventional drugs, but clinical guidelines are still crucial.  

Can Medical Cannabis Help Reduce Morning Stiffness? 

So is prescribed medical cannabis actually able to decrease morning stiffness resulting from arthritis? 
Though strong clinical data are lacking, anecdotal evidence and some preclinical studies indicate that cannabinoids might decrease inflammation and enhance joint comfort, particularly in the morning, when stiffness is worst. 
CBD, specifically, has been researched for its effect on joint inflammation, and some have indicated it can inhibit pro-inflammatory cytokines and enzymes. Users reported increased sleep and less pain, which could indirectly reduce morning stiffness. 
But medical cannabis needs to be prescribed cautiously. Accurate medical guidance and control are essential. Various forms and modes of delivery, e.g. oral oils, capsules, or transdermal CBD patches, are prescribed on a case-by-case basis according to patient requirements and clinical assessment. 
Patients using medical cannabis Releaf from licensed centers typically consult closely with experts to customise the treatment for their specific arthritis profile and medical history.  

Best Cannabis Types for Arthritis-Related Inflammation 

Cannabis is not a single substance. It contains a variety of cannabinoids, strains, and formulations. Some types may be better for inflammatory conditions such as arthritis, but more studies are required to determine best practice.  

Cannabinoids with Anti-Inflammatory Effects 

In addition to CBD and THC, other cannabinoids like CBG (cannabigerol) and certain synthetic cannabinoids are also under investigation for their capacity to reduce inflammation. 

Initial studies indicate that cannabinoids might:  

  • Suppress inflammatory cytokine production 
  • Inhibit synovial fibroblasts, which cause joint damage 
  • Decrease oxidative stress and joint degradation 

These mechanisms offer promise but have yet to be confirmed in large-scale human trials. 

Cannabis Strains That May Help 

There are numerous varieties of cannabis, each with a unique cannabinoid content. Some that are often mentioned for symptoms of arthritis are  

  • High-CBD strains: ACDC, Cannatonic, Charlotte’s Web, and Harlequin may help with inflammation without causing intoxication. 
  • Balanced CBD: THC strains: Harlequin offers both cannabinoids in a more balanced ratio. 
  • High-THC strains: These can provide pain relief to some patients but can induce psychoactive effects, which are not tolerated well by all. 

Patient history, severity of symptoms, and sensitivity are taken into consideration by the prescriber while choosing an appropriate product.  

Full-Spectrum and Synergistic Effects 

Full-spectrum cannabis products have a combination of cannabinoids, terpenes, and flavonoids, which could potentially work together to maximize therapeutic effects, an effect referred to as the entourage effect. 
Although some scientists are convinced this synergy optimizes results, existing evidence remains in the process of emerging, and not all full-spectrum products are created equal.  

Evidence Caveat 

Most of the evidence regarding medical cannabis and arthritis is based on animal research, preclinical studies, or small numbers of people. Controlled, larger clinical trials must be conducted before conclusions can be firmly made. 
Patients thinking about trying cannabis-based treatments should see a medical expert and realize that results are highly variable.  

Who Might Benefit and Who Should Be Cautious 

Medical cannabis may be appropriate for some arthritis patients, particularly those who have not responded to conventional treatments such as NSAIDs, DMARDs, or physical therapy. 

However, it is not suitable for everyone. Caution is advised in the following groups: 

  • Pregnant or lactating women 
  • Patients with a history of psychosis or major mental illness  
  • Individuals with heart or liver disease 
  • Patients on medications which can interact with cannabinoids 

In the UK, medical cannabis is prescribed only by a specialist clinician. It cannot be purchased over-the-counter or legally used for recreational purposes.  

For Further information on eligibility and legal access, see Leafease providing access to medical cannabis Releaf will undertake thorough assessments to confirm patient suitability.  

Final Thoughts 

Some patients with arthritis report that prescribed medical cannabis helps them manage pain and reduce morning stiffness, particularly when conventional options have not provided relief. 
However, medical cannabis is not a cure, nor is it a one-size-fits-all solution. Outcomes vary, and any use must be managed under medical supervision, in line with UK laws.  

If you’re considering cannabis-based therapy for arthritis: 

Speak with a providers like Leafease about personalised options 

Learn more about legal and clinical routes. 

Dr. Clarissa Morton, PharmD
Author

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy. 

Categories